We found that naïve CD4+ T cells in HBV-HCC patients were significantly lower than healthy volunteers (p<0.05), and naïve CD4+ T cells in HBV-HCC patients were lower than those in HBV-LC patients (Figure 2A). The gene discussed is CD4; the disease is laryngotracheoesophageal cleft.